Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R. Kalra, Claes Christian Strom, Fozia Ahmed et al.|The Lancet|2022Cited by 367
How to Handle Polypharmacy in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESCDavide Stolfo, Gianluigi Savarese, Massimo Iacoviello et al.|European Journal of Heart Failure|2025Cited by 36
Assessment of Frailty in Patients with Heart Failure: A New Heart Failure Frailty Score Developed by Delphi ConsensusCristiana Vitale, Anna Strömberg, Emmanuelle Berthelot et al.|ESC Heart Failure|2025Cited by 11